Content provided by our partners. Learn how to advertise.

Maryland Oncology Hematology 

Aquilino Cancer Center – Rockville, Bethesda and Germantown
301-424-6231
MarylandOncology.com

For nearly 40 years, Maryland Oncology Hematology (MOH) has been a leading provider of community cancer care and treatment of blood disorders in suburban Maryland. The state’s largest independent Medical Oncology and Hematology group with over 52 physicians across 15 locations in central Maryland, MOH’s highly specialized team of board-certified physicians provides the highest level of expertise and cutting-edge treatment options for patients throughout the state. 

At MOH, personalized treatment is paramount. The team of dedicated and compassionate award-winning physicians, nurses and staff are committed to guiding patients through every step of their cancer journey, using sophisticated technology and offering expertise in targeted agents, immunotherapies and other innovative treatments. MOH’s state-of-the-art facilities deliver a comprehensive range of services, including oncological and non-oncological infusions, laboratory testing, clinical trials with Sarah Cannon Research Institute, genetic counseling and patient support services.   

MOH’s commitment to excellence extends far beyond providing top-notch treatments. As part of the US Oncology Network, MOH actively participates in clinical trials that have contributed to FDA-approved therapies, ensuring patients have access to the most advanced and effective treatments available. 

Combining leading-edge technology and expert, empathetic care, MOH delivers world-class treatment for cancer and blood disorders while keeping patients close to home. 

Maryland Oncology Hematology is Maryland’s largest independent oncology practice, with more than 52 practicing clinicians devoted to providing comprehensive, compassionate, high-quality cancer care. A part of The US Oncology Network, Maryland Oncology Hematology patients benefit from a community of 2,300-plus independent providers dedicated to advancing local cancer care and delivering better patient outcomes.